Health Condition 1: E119- Type 2 diabetes mellitus without complications
Conditions
Interventions
Intervention1: Vildagliptin plus Metformin: One arm will receive tablet Vildagliptin 50mg twice daily before meals plus tablet Metformin 500mg two tablets in the morning after breakfast, one tablet in
Sponsors
Dr Bratati Sanyal
Eligibility
Inclusion criteria
Inclusion criteria: Patients of either sex aged from 18 to 65, who are on oral Metformin therapy of 2000mg/day for type 2 diabetes mellitus for at least six months and with HbA1c values between 6.5 to 9, attending the General Medicine OPD of college of Medicine & Sagore Dutta Hospital, Kamarhati, Kolkata.
Exclusion criteria
Exclusion criteria: Pregnant and lactating women and patients planning for pregnancy in next few months. Patients suffering from any acute illness at the time of screening. Patients with known history of any hypersensitivity reactions from any of the study drugs. Patients who have already enrolled for any other ongoing clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the efficacies of Vildagliptin and Dapagliflozin in terms of reduction of HbA1c from baseline. To compare the safety of Vildagliptin and Dapagliflozin Timepoint: 0, 12 weeks, 24 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the reduction in FBS, PPBS, lipid profile, serum urea, creatinine, ACR in case of Vildagliptin and DapagliflozinTimepoint: 0, 12 weeks, 24 weeks | — |
Countries
India
Contacts
Public ContactDr Bratati Sanyal
College of Medicine And Sagore Dutta Hospital
Outcome results
None listed